Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 2/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | TP53 | P04637 | 2/20 | 0.41 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12102581 | 0.96 | THRB (0.45) | THRBNPC1RAB9AMEN1KMT2A | |
| SCHEMBL822751 | 0.91 | CNR2 (0.42) | NPC1RAB9ACNR2CNR1MAPT | |
| SCHEMBL822452 | 0.88 | MEN1 (0.45) | THRBNPC1RAB9AMEN1KMT2A | |
| SCHEMBL823207 | 0.86 | THRB (0.49) | THRBNPC1RAB9AMEN1KMT2A | |
| SCHEMBL822568 | 0.85 | MAPT (0.44) | NPC1RAB9ACNR2CNR1MAPT | |
| SCHEMBL12104600 | 0.83 | THRB (0.47) | THRBNPC1RAB9AMEN1KMT2A | |
| SCHEMBL12120670 | 0.80 | KMT2A (0.45) | THRBNPC1RAB9AMEN1KMT2A | |
| SCHEMBL822567 | 0.76 | KMT2A (0.42) | NPC1RAB9AMEN1KMT2ACNR2 | |
| SCHEMBL823143 | 0.76 | KDM4E (0.52) | NPC1RAB9ACNR2CNR1MAPT | |
| SCHEMBL822453 | 0.75 | MEN1 (0.39) | THRBNPC1RAB9AMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8530270-B2 | Methods of preparing semiconductive compositions and devices | EASTMAN KODAK COMPANY (US) | 2013-09-10 | — | — | US | disclosed |
| US-8411489-B2 | Semiconducting devices and methods of preparing | EASTMAN KODAK COMPANY (US) | 2013-04-02 | — | — | US | disclosed |
| US-8314265-B2 | Aromatic amic acids or amic esters and compositions | EASTMAN KODAK COMPANY (US) | 2012-11-20 | — | — | US | disclosed |
| US-20110269967-A1 | AROMATIC AMIC ACIDS OR AMIC ESTERS AND COMPOSITIONS | BANK OF AMERICA, N.A., AS AGENT | 2011-11-03 | — | — | US | disclosed |
| US-20110269966-A1 | SEMICONDUCTING ARTICLES | CITICORP NORTH AMERICA, INC., AS AGENT | 2011-11-03 | — | — | US | disclosed |
| US-20110269265-A1 | METHODS OF PREPARING SEMICONDUCTIVE COMPOSITIONS AND DEVICES | KODAK REALTY INC. | 2011-11-03 | — | — | US | disclosed |
| US-20110266523-A1 | SEMICONDUCTING DEVICES AND METHODS OF PREPARING | BANK OF AMERICA, N.A., AS AGENT | 2011-11-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110269966-A1 | SEMICONDUCTING ARTICLES | ALAD, PORCN, DDC | THRB 3732/4885NPC1 2148/4885RAB9A 2482/4885 |
| US-20110269967-A1 | AROMATIC AMIC ACIDS OR AMIC ESTERS AND COMPOSITIONS | DDC, AADAC, MYOC | THRB 2869/4885NPC1 2077/4885RAB9A 1518/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.